John D. Chovan, James R. Cacchillo
Treatment, Neurological Diseases
Immune System Diseases | Medical Pathology | Nursing
Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease characterized by ocular, bulbar, facial, and skeletal muscle weakness due to a defect in the transmission of nerve to muscle impulses at the neuromuscular junction (Mestecky, 2013, p. 110). Approximately 14-20 in 100,000 people are diagnosed with myasthenia gravis in the United States (Leis, Moore, Kofler, Beric, De Visser, 2014, p. 112). Typically, diagnosis occurs in middle-aged adults with women generally acquiring the disease at a younger age than men (Mestecky, 2013, p. 110). MG has the potential to greatly affect the quality of life of a patient. Although the disease may go into remission for any given amount of time, there is currently no known cure for myasthenia gravis. Patients experience varying degrees of symptoms, however, there are several treatment options available to help those with MG decrease symptoms and lead full lives.
Feaver, Abbe R., "Myasthenia Gravis" (2015). Master of Science in Nursing (MSN) Student Scholarship. Paper 62.